Expertise in
7
conditions

Bernhard J. Eigl

BC, CA 
Expertise in
7
conditions
BC, CA 

Overview

Bernhard Eigl practices practicing medicine in Canada.

Mr. Eigl is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Teratoma of the Mediastinum, Testicular Cancer, Urothelial Cancer, Orchiectomy, and Cystectomy.

He is actively involved in clinical research, co-authoring 83 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

BC, Canada
Other Locations
BC Cancer
Vancouver, BC V5Z4E6, Canada
Surrey
Surrey, BC, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Enrollment Status: Terminated
Publish Date: March 13, 2024
Intervention Type: Drug
Study Drug: Infigratinib
Study Phase: Phase 3
A Randomized Phase II Study of Sequencing Abiraterone Acetate and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
A Randomized Phase II Study of Sequencing Abiraterone Acetate and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Enrollment Status: Completed
Publish Date: August 07, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

83 Total Publications

NeoBLAST: A Pilot Randomized Controlled Trial of Active Surveillance Versus Definitive Bladder Treatment Following Clinical Complete Response to Neoadjuvant Therapy in Muscle-invasive Bladder Cancer - Study Protocol.
NeoBLAST: A Pilot Randomized Controlled Trial of Active Surveillance Versus Definitive Bladder Treatment Following Clinical Complete Response to Neoadjuvant Therapy in Muscle-invasive Bladder Cancer - Study Protocol.
Journal: European urology oncology
Published: March 23, 2026

Frequently Asked Questions about Bernhard J. Eigl

Is Bernhard J. Eigl a top-rated expert for Teratoma of the Mediastinum?

MediFind is an objective health platform that identifies experts based on real-world data. Bernhard J. Eigl is classified as an Distinguished expert for Teratoma of the Mediastinum, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Bernhard J. Eigl participate in research or clinical trials?

Yes. Bernhard J. Eigl has published 83 articles and abstracts on conditions like Teratoma of the Mediastinum. You can view a list of Bernhard J. Eigl's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Eigl's expertise for a condition
ConditionClose
    View All 10 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile